PetDx

About:

PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.

Website: https://petdx.com

Twitter/X: PetDxInc/

Top Investors: Valor Equity Partners, LabCorp, Petco, Torch Capital, Tech Coast Angels

Description:

PetDx® – The Liquid Biopsy Company for Pets is a San Diego-based molecular diagnostics company dedicated to unleashing the power of genomics to improve pet health. The company's flagship product, OncoK9®, enables veterinarians to detect cancer in dogs with a simple blood draw. As a first-in-class multi-cancer early detection (MCED) test, OncoK9 employs cutting-edge genomic analysis that leverages next-generation sequencing (NGS) technology and proprietary bioinformatics algorithms, empowering veterinarians to provide superior care to canine patients.